CRN's summary of the dietary supplement advertising decisions issued by the National Advertising Division (NAD) in conjunction with the CRN/NAD Advertising Review Program can help stakeholders better understand what claims raise red flags—so they can avoid making these kinds of claims.
Frequently Asked Questions
CRN is part of the SIDI Work Group, whose expert volunteers develop guidelines as tools for the dietary supplement industry.
Recommended Guidelines for Labeling and Formulation of Melatonin-containing Dietary Supplements for Sleep Support
Melatonin is a naturally occurring hormone made by the pineal gland which helps to control sleep and wake cycles. It is a dietary ingredient present in dietary supplements used for sleep support. Printable PDF
This free online tool compiles FDA Warning Letters sent to dietary supplement companies into a searchable database to help industry achieve better regulatory compliance. The database can be used to evaluate FDA’s warning letter allegations of good manufacturing practices (GMPs) violations, products making impermissible claims, and products tainted with illegal ingredients.
CRN and its members share a commitment to improving public health through nutrition, including the appropriate use of dietary supplements and functional food1.In pursuit of this goal, CRN’s members pledge to observe and uphold the highest ethical principles in their dealings with their customers, suppliers, competitors, regulators and consumers in order to foster confidence in our products. In particular, CRN and its members commit themselves to the following ethical principles
CRN recommends that marketers of dietary supplements and functional foods adhere to the following guidelines in labeling the protein content in any such product:
Industry Initiative Targets Deceptive, False and Misleading Dietary Supplement Advertising